Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    11782102 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Multicenter Study of NAP (AL-108) in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: AL-108;   Drug: Placebo
2 Unknown  Genetic Expression in Schizophrenics Treated With SSRI Augmentation: Relationship to Clinical and Cognitive Function
Condition: Schizophrenia
Intervention: Drug: Fluvoxamine

Indicates status has not been verified in more than two years